nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—type 2 diabetes mellitus	0.29	1	CbGaD
Gadobenate Dimeglumine—ALB—Gliclazide—type 2 diabetes mellitus	0.0972	0.204	CbGbCtD
Gadobenate Dimeglumine—ALB—Repaglinide—type 2 diabetes mellitus	0.0914	0.192	CbGbCtD
Gadobenate Dimeglumine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0763	0.16	CbGbCtD
Gadobenate Dimeglumine—ALB—Valsartan—type 2 diabetes mellitus	0.0674	0.142	CbGbCtD
Gadobenate Dimeglumine—ALB—Nateglinide—type 2 diabetes mellitus	0.0627	0.132	CbGbCtD
Gadobenate Dimeglumine—ALB—Glyburide—type 2 diabetes mellitus	0.0423	0.0889	CbGbCtD
Gadobenate Dimeglumine—ALB—Losartan—type 2 diabetes mellitus	0.0387	0.0813	CbGbCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.000121	0.00275	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CRP—type 2 diabetes mellitus	0.000121	0.00275	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000119	0.0027	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000118	0.00269	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.000117	0.00267	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—APOA1—type 2 diabetes mellitus	0.000117	0.00266	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—CD36—type 2 diabetes mellitus	0.000115	0.00261	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.000115	0.0026	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—SERPINE1—type 2 diabetes mellitus	0.000114	0.00259	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—ICAM1—type 2 diabetes mellitus	0.000111	0.00252	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—GRB14—type 2 diabetes mellitus	0.00011	0.0025	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—CD36—type 2 diabetes mellitus	0.000109	0.00249	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.000109	0.00248	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—RELA—type 2 diabetes mellitus	0.000102	0.00233	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—CALM1—type 2 diabetes mellitus	0.000102	0.00231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—INS—type 2 diabetes mellitus	0.000101	0.0023	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.000101	0.00229	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000101	0.00229	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—APOA1—type 2 diabetes mellitus	0.0001	0.00228	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.0001	0.00227	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CCL2—type 2 diabetes mellitus	9.94e-05	0.00226	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	9.72e-05	0.00221	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—CALM1—type 2 diabetes mellitus	9.69e-05	0.0022	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	9.6e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—type 2 diabetes mellitus	9.55e-05	0.00217	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	9.48e-05	0.00215	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	9.28e-05	0.00211	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SERPINE1—type 2 diabetes mellitus	9.28e-05	0.00211	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—type 2 diabetes mellitus	9.11e-05	0.00207	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	8.82e-05	0.002	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—NFKB1—type 2 diabetes mellitus	8.64e-05	0.00196	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TRPC6—type 2 diabetes mellitus	8.53e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—IGF1—type 2 diabetes mellitus	8.38e-05	0.0019	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—RELA—type 2 diabetes mellitus	8.34e-05	0.00189	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Sitagliptin—type 2 diabetes mellitus	8.13e-05	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.13e-05	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Headache—Glimepiride—type 2 diabetes mellitus	8.11e-05	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	8.09e-05	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Cough—Irbesartan—type 2 diabetes mellitus	8.09e-05	0.000427	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.08e-05	0.00184	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Sitagliptin—type 2 diabetes mellitus	8.08e-05	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Losartan—type 2 diabetes mellitus	8.06e-05	0.000426	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	8.02e-05	0.00182	CbGpPWpGaD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.02e-05	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Irbesartan—type 2 diabetes mellitus	8e-05	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.99e-05	0.000422	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—type 2 diabetes mellitus	7.98e-05	0.00181	CbGpPWpGaD
Gadobenate Dimeglumine—Flushing—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Losartan—type 2 diabetes mellitus	7.97e-05	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Infection—Metformin—type 2 diabetes mellitus	7.96e-05	0.00042	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—SERPINE1—type 2 diabetes mellitus	7.95e-05	0.00181	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.93e-05	0.0018	CbGpPWpGaD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.93e-05	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.91e-05	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.9e-05	0.000417	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	7.89e-05	0.00179	CbGpPWpGaD
Gadobenate Dimeglumine—Myalgia—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Shock—Metformin—type 2 diabetes mellitus	7.89e-05	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Losartan—type 2 diabetes mellitus	7.87e-05	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Irbesartan—type 2 diabetes mellitus	7.86e-05	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.86e-05	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.86e-05	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Losartan—type 2 diabetes mellitus	7.82e-05	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.81e-05	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Losartan—type 2 diabetes mellitus	7.81e-05	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Metformin—type 2 diabetes mellitus	7.79e-05	0.000411	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.76e-05	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.75e-05	0.000409	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.75e-05	0.000409	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000409	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.72e-05	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000407	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.72e-05	0.00175	CbGpPWpGaD
Gadobenate Dimeglumine—Palpitations—Losartan—type 2 diabetes mellitus	7.71e-05	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Glimepiride—type 2 diabetes mellitus	7.69e-05	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000405	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.67e-05	0.000405	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.66e-05	0.00174	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.66e-05	0.00174	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.66e-05	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Glyburide—type 2 diabetes mellitus	7.66e-05	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Cough—Losartan—type 2 diabetes mellitus	7.61e-05	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.61e-05	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.6e-05	0.000401	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Valsartan—type 2 diabetes mellitus	7.59e-05	0.000401	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—type 2 diabetes mellitus	7.58e-05	0.00172	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.57e-05	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.57e-05	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Glyburide—type 2 diabetes mellitus	7.55e-05	0.000399	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.53e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—Mental disorder—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Valsartan—type 2 diabetes mellitus	7.53e-05	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Infection—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.51e-05	0.000396	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—ADRA2A—type 2 diabetes mellitus	7.51e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—Fatigue—Orlistat—type 2 diabetes mellitus	7.5e-05	0.000396	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Metformin—type 2 diabetes mellitus	7.49e-05	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000395	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TIMP1—type 2 diabetes mellitus	7.47e-05	0.0017	CbGpPWpGaD
Gadobenate Dimeglumine—Shock—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Pain—Orlistat—type 2 diabetes mellitus	7.44e-05	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Losartan—type 2 diabetes mellitus	7.43e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Losartan—type 2 diabetes mellitus	7.43e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Losartan—type 2 diabetes mellitus	7.43e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.42e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Losartan—type 2 diabetes mellitus	7.4e-05	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.00039	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	7.37e-05	0.00167	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	7.37e-05	0.00167	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Bromocriptine—type 2 diabetes mellitus	7.36e-05	0.000389	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.35e-05	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Losartan—type 2 diabetes mellitus	7.34e-05	0.000387	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000387	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Headache—Bromocriptine—type 2 diabetes mellitus	7.31e-05	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.3e-05	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.3e-05	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Losartan—type 2 diabetes mellitus	7.26e-05	0.000383	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.2e-05	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Metformin—type 2 diabetes mellitus	7.2e-05	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.19e-05	0.00038	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	7.18e-05	0.00163	CbGpPWpGaD
Gadobenate Dimeglumine—Confusional state—Losartan—type 2 diabetes mellitus	7.18e-05	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000378	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.15e-05	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Metformin—type 2 diabetes mellitus	7.13e-05	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.12e-05	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000375	CcSEcCtD
Gadobenate Dimeglumine—Infection—Losartan—type 2 diabetes mellitus	7.07e-05	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.06e-05	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Metformin—type 2 diabetes mellitus	7.06e-05	0.000373	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—NFKB1—type 2 diabetes mellitus	7.03e-05	0.0016	CbGpPWpGaD
Gadobenate Dimeglumine—Tremor—Ramipril—type 2 diabetes mellitus	7.01e-05	0.00037	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.01e-05	0.00159	CbGpPWpGaD
Gadobenate Dimeglumine—Shock—Losartan—type 2 diabetes mellitus	7e-05	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Valsartan—type 2 diabetes mellitus	6.99e-05	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.98e-05	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Losartan—type 2 diabetes mellitus	6.95e-05	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Bromocriptine—type 2 diabetes mellitus	6.93e-05	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.92e-05	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Metformin—type 2 diabetes mellitus	6.91e-05	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Orlistat—type 2 diabetes mellitus	6.91e-05	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000364	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.88e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.88e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Metformin—type 2 diabetes mellitus	6.86e-05	0.000362	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	6.85e-05	0.00156	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	6.85e-05	0.00156	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	6.85e-05	0.00156	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	6.84e-05	0.00155	CbGpPWpGaD
Gadobenate Dimeglumine—Angioedema—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Glyburide—type 2 diabetes mellitus	6.78e-05	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Gliclazide—type 2 diabetes mellitus	6.78e-05	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Rash—Glyburide—type 2 diabetes mellitus	6.73e-05	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000355	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	6.73e-05	0.00153	CbGpPWpGaD
Gadobenate Dimeglumine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.72e-05	0.000355	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	6.72e-05	0.00153	CbGpPWpGaD
Gadobenate Dimeglumine—Syncope—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000354	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Headache—Glyburide—type 2 diabetes mellitus	6.69e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.000352	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Losartan—type 2 diabetes mellitus	6.65e-05	0.000351	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	6.62e-05	0.00151	CbGpPWpGaD
Gadobenate Dimeglumine—Palpitations—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.61e-05	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000347	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.56e-05	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.53e-05	0.000345	CcSEcCtD
Gadobenate Dimeglumine—Cough—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000345	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000344	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.49e-05	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.49e-05	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Pain—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000342	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	6.44e-05	0.00146	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.41e-05	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Losartan—type 2 diabetes mellitus	6.39e-05	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Metformin—type 2 diabetes mellitus	6.37e-05	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.35e-05	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Glyburide—type 2 diabetes mellitus	6.34e-05	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.34e-05	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.34e-05	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Losartan—type 2 diabetes mellitus	6.33e-05	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Valsartan—type 2 diabetes mellitus	6.32e-05	0.000333	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	6.31e-05	0.00143	CbGpPWpGaD
Gadobenate Dimeglumine—Discomfort—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Losartan—type 2 diabetes mellitus	6.27e-05	0.000331	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.26e-05	0.00142	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.25e-05	0.00142	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.25e-05	0.00142	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.21e-05	0.00141	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000327	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Losartan—type 2 diabetes mellitus	6.14e-05	0.000324	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.11e-05	0.00139	CbGpPWpGaD
Gadobenate Dimeglumine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000322	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	6.09e-05	0.00138	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.09e-05	0.000322	CcSEcCtD
Gadobenate Dimeglumine—Pain—Losartan—type 2 diabetes mellitus	6.09e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Losartan—type 2 diabetes mellitus	6.09e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Rash—Gliclazide—type 2 diabetes mellitus	6.04e-05	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.04e-05	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000318	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.01e-05	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.01e-05	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Shock—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gliclazide—type 2 diabetes mellitus	6e-05	0.000317	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6e-05	0.00136	CbGpPWpGaD
Gadobenate Dimeglumine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000316	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000315	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000314	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000313	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.91e-05	0.00134	CbGpPWpGaD
Gadobenate Dimeglumine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000312	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	5.89e-05	0.00134	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.87e-05	0.00031	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.82e-05	0.000307	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Valsartan—type 2 diabetes mellitus	5.82e-05	0.000307	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	5.79e-05	0.00131	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Orlistat—type 2 diabetes mellitus	5.75e-05	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Metformin—type 2 diabetes mellitus	5.75e-05	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gliclazide—type 2 diabetes mellitus	5.69e-05	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Metformin—type 2 diabetes mellitus	5.67e-05	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Losartan—type 2 diabetes mellitus	5.66e-05	0.000299	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	5.63e-05	0.00128	CbGpPWpGaD
Gadobenate Dimeglumine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.63e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.63e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Valsartan—type 2 diabetes mellitus	5.6e-05	0.000295	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	5.59e-05	0.00127	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.57e-05	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Rash—Valsartan—type 2 diabetes mellitus	5.55e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.55e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Orlistat—type 2 diabetes mellitus	5.53e-05	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Headache—Valsartan—type 2 diabetes mellitus	5.52e-05	0.000291	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.49e-05	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Rash—Orlistat—type 2 diabetes mellitus	5.48e-05	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.48e-05	0.000289	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	5.47e-05	0.00124	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	5.47e-05	0.00124	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.46e-05	0.00124	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Orlistat—type 2 diabetes mellitus	5.45e-05	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000286	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	5.42e-05	0.00123	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000284	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—THBD—type 2 diabetes mellitus	5.36e-05	0.00122	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Metformin—type 2 diabetes mellitus	5.3e-05	0.00028	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.25e-05	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Valsartan—type 2 diabetes mellitus	5.23e-05	0.000276	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000276	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	5.21e-05	0.00118	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.19e-05	0.00118	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.19e-05	0.00118	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000273	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Orlistat—type 2 diabetes mellitus	5.17e-05	0.000273	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.11e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Losartan—type 2 diabetes mellitus	5.11e-05	0.00027	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.1e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Metformin—type 2 diabetes mellitus	5.1e-05	0.000269	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	5.1e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—BHMT—type 2 diabetes mellitus	5.09e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Metformin—type 2 diabetes mellitus	5.05e-05	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Metformin—type 2 diabetes mellitus	5.05e-05	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Losartan—type 2 diabetes mellitus	5.04e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Headache—Metformin—type 2 diabetes mellitus	5.02e-05	0.000265	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	5.02e-05	0.00114	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Irbesartan—type 2 diabetes mellitus	5e-05	0.000264	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000264	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.94e-05	0.00112	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.87e-05	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	4.78e-05	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Metformin—type 2 diabetes mellitus	4.76e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Headache—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.00025	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.73e-05	0.00108	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Losartan—type 2 diabetes mellitus	4.71e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	4.53e-05	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Losartan—type 2 diabetes mellitus	4.53e-05	0.000239	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	4.51e-05	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Rash—Losartan—type 2 diabetes mellitus	4.49e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Losartan—type 2 diabetes mellitus	4.49e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Headache—Losartan—type 2 diabetes mellitus	4.46e-05	0.000235	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	4.45e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AANAT—type 2 diabetes mellitus	4.45e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	4.44e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	4.41e-05	0.001	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	4.4e-05	0.000999	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.34e-05	0.000987	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F7—type 2 diabetes mellitus	4.32e-05	0.000982	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	4.24e-05	0.000964	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.23e-05	0.000962	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Losartan—type 2 diabetes mellitus	4.23e-05	0.000223	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—GPD2—type 2 diabetes mellitus	4.22e-05	0.000959	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CDO1—type 2 diabetes mellitus	4.22e-05	0.000959	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.18e-05	0.00022	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.12e-05	0.000937	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.11e-05	0.000934	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.1e-05	0.000932	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000213	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—AK1—type 2 diabetes mellitus	4.03e-05	0.000915	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.98e-05	0.000904	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.92e-05	0.000891	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.92e-05	0.000891	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000205	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	3.87e-05	0.000879	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	3.85e-05	0.000875	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	3.85e-05	0.000875	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.83e-05	0.00087	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Ramipril—type 2 diabetes mellitus	3.82e-05	0.000202	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.81e-05	0.000865	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.78e-05	0.00086	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	3.72e-05	0.000844	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	3.72e-05	0.000844	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	3.72e-05	0.000844	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	3.71e-05	0.000844	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.7e-05	0.000841	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.63e-05	0.000825	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000191	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	3.62e-05	0.000823	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.6e-05	0.000818	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ND1—type 2 diabetes mellitus	3.59e-05	0.000815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HBA2—type 2 diabetes mellitus	3.59e-05	0.000815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	3.59e-05	0.000815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—G6PC—type 2 diabetes mellitus	3.59e-05	0.000815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.59e-05	0.000815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	3.53e-05	0.000802	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	3.52e-05	0.000801	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.51e-05	0.000797	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCGR—type 2 diabetes mellitus	3.48e-05	0.00079	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	3.47e-05	0.000788	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	3.37e-05	0.000765	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.35e-05	0.00076	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.33e-05	0.000758	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	3.28e-05	0.000746	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYTB—type 2 diabetes mellitus	3.28e-05	0.000746	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	3.2e-05	0.000727	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.18e-05	0.000723	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	3.14e-05	0.000714	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ACACA—type 2 diabetes mellitus	3.05e-05	0.000693	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	3.05e-05	0.000693	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—STAR—type 2 diabetes mellitus	3.05e-05	0.000693	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.05e-05	0.000693	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	3.04e-05	0.00069	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	2.98e-05	0.000678	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CBS—type 2 diabetes mellitus	2.93e-05	0.000665	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	2.93e-05	0.000665	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—APOB—type 2 diabetes mellitus	2.9e-05	0.000658	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—COX2—type 2 diabetes mellitus	2.82e-05	0.00064	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	2.82e-05	0.00064	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	2.77e-05	0.000629	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.76e-05	0.000628	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UCP3—type 2 diabetes mellitus	2.72e-05	0.000618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UCP2—type 2 diabetes mellitus	2.72e-05	0.000618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	2.72e-05	0.000618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.64e-05	0.000599	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.63e-05	0.000597	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CD36—type 2 diabetes mellitus	2.63e-05	0.000597	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.62e-05	0.000595	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	2.59e-05	0.00059	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.59e-05	0.000589	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PCK1—type 2 diabetes mellitus	2.56e-05	0.000581	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.52e-05	0.000572	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.51e-05	0.00057	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	2.49e-05	0.000566	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.46e-05	0.000558	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	2.43e-05	0.000551	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	2.4e-05	0.000544	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HK1—type 2 diabetes mellitus	2.39e-05	0.000544	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.39e-05	0.000543	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.34e-05	0.000532	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	2.33e-05	0.000529	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCKR—type 2 diabetes mellitus	2.31e-05	0.000525	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	2.31e-05	0.000525	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	2.31e-05	0.000525	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LPA—type 2 diabetes mellitus	2.31e-05	0.000525	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	2.29e-05	0.000521	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	2.23e-05	0.000506	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.22e-05	0.000505	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	2.22e-05	0.000504	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	2.19e-05	0.000497	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	2.16e-05	0.000491	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.15e-05	0.000489	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.11e-05	0.00048	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.11e-05	0.000479	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.09e-05	0.000474	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	2.06e-05	0.000468	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.98e-05	0.000451	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.92e-05	0.000437	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.92e-05	0.000435	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.91e-05	0.000435	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.89e-05	0.000428	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.89e-05	0.000428	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.85e-05	0.00042	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.84e-05	0.000418	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.84e-05	0.000417	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.84e-05	0.000417	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.84e-05	0.000417	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.83e-05	0.000415	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.82e-05	0.000413	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.79e-05	0.000407	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.77e-05	0.000403	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.74e-05	0.000395	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.74e-05	0.000395	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.65e-05	0.000374	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.65e-05	0.000374	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.65e-05	0.000374	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.62e-05	0.000368	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.6e-05	0.000364	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.58e-05	0.000359	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.57e-05	0.000356	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.55e-05	0.000352	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.51e-05	0.000342	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.49e-05	0.000339	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.49e-05	0.000339	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.45e-05	0.00033	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.45e-05	0.000329	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.43e-05	0.000325	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.43e-05	0.000325	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.28e-05	0.000292	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.25e-05	0.000284	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.23e-05	0.00028	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.23e-05	0.00028	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.23e-05	0.000279	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.21e-05	0.000275	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.17e-05	0.000267	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	1.15e-05	0.000261	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	1.14e-05	0.00026	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—LPL—type 2 diabetes mellitus	1.12e-05	0.000255	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.1e-05	0.000249	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.09e-05	0.000249	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.07e-05	0.000242	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.05e-05	0.000239	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.01e-05	0.000229	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARA—type 2 diabetes mellitus	9.9e-06	0.000225	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AGT—type 2 diabetes mellitus	9.59e-06	0.000218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CALM1—type 2 diabetes mellitus	9.43e-06	0.000214	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOE—type 2 diabetes mellitus	9.4e-06	0.000214	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOA1—type 2 diabetes mellitus	9.29e-06	0.000211	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPARG—type 2 diabetes mellitus	8.18e-06	0.000186	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—INS—type 2 diabetes mellitus	8.03e-06	0.000182	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	7.98e-06	0.000181	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NOS3—type 2 diabetes mellitus	7.04e-06	0.00016	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	7.04e-06	0.00016	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	6.44e-06	0.000146	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	3.24e-06	7.35e-05	CbGpPWpGaD
